Sandbox:lipid: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 44: | Line 44: | ||
|- | |- | ||
|Aortic valve morphology | |Aortic valve morphology | ||
|'''TTE''': | |'''[[TTE]]''': | ||
* Trileaflet, bicuspid or unicuspid | * Trileaflet, bicuspid or unicuspid | ||
* Valve calcification | * Valve [[calcification]] | ||
* Leaflet motion | * Leaflet motion | ||
Line 53: | Line 53: | ||
* Annular size and shape | * Annular size and shape | ||
| | | | ||
* TEE if can be safely performed, particularly | * [[TEE]] if can be safely performed, particularly | ||
useful for subaortic membranes | useful for subaortic membranes | ||
* Cardiac MRI if echocardiography | * Cardiac MRI if echocardiography | ||
Line 60: | Line 60: | ||
contraindicated | contraindicated | ||
|- | |- | ||
|Aortic valve function | |||
|'''[[TTE]]:''' | |||
* Maximum aortic velocity | |||
* Mean aortic valve gradient | |||
* Aortic valve area | |||
* Stroke volume index | |||
* Presence and severity of AR | |||
|Additional parameters | |||
* Dimensionless index | |||
* AVA by planimetry (echo, CT, MRI) | |||
* Dobutamine stress echocardiography | |||
for LFLG AS-Reduced EF | |||
* Aortic valve calcium score if LFLG AS | |||
diagnosis in question | |||
|- | |||
|LV Geometry and other | |||
cardiac findings | |||
|'''[[TTE|TTE:]]''' | |||
* LVEF, regional wall motion | |||
* Hypertrophy, diastolic dysfunction | |||
* Pulmonary pressure estimate | |||
* Mitral valve (MR, MS, MAC) | |||
* Aortic sinus anatomy and size | |||
| | |||
* Myocardial ischemia and scar: CMR, PET, | |||
DSE, thallium | |||
* CMR imaging for myocardial fibrosis and | |||
scar, identification of cardiomyopathies | |||
|- | |||
|Annular sizing | |||
| | | | ||
* TAVR CTA- gated contrast enhanced CT | |||
thorax with multiphasic acquisition | |||
* Typically reconstructed in systole 30-40% | |||
of the R-R window | |||
| | | | ||
* Major/minor annulus dimension | |||
* Major/minor average | |||
* Annular area | |||
* Circumference/perimeter | |||
|- | |||
|Aortic root measurements | |||
| | | | ||
* Gated contrast-enhanced CT thorax with | |||
multiphasic acquisition. | |||
* Typically reconstructed in diastole 60%–80%. | |||
| | |||
* Coronary ostia heights | |||
* Midsinus of Valsalva (sinus to commissure, | |||
sinus to sinus) | |||
* Sinotubular junction | |||
* Ascending aorta (40 cm above valve plane, | |||
widest dimension, at level of PA) | |||
* Aortic root and ascending aorta calcification | |||
|- | |- | ||
|Coronary disease and | |||
thoracic anatomy | |||
| | | | ||
* Coronary angiography | |||
* Nongated thoracic CTA | |||
| | | | ||
* Coronary artery disease severity | |||
* Bypass grafts: number/location | |||
* RV to chest wall distance | |||
* Aorta to chest wall relationship | |||
|- | |||
|Noncardiac imaging | |||
| | | | ||
* Carotid ultrasound | |||
* Cerebrovascular MRI | |||
|May be considered depending on clinical | |||
history | |||
|} | |} |
Revision as of 21:02, 12 January 2017
TAVR Imaging Evaluation | |||||||||||||||||||||||||||||||||||||||||||||||||||
TAVR CT | ECHO | ||||||||||||||||||||||||||||||||||||||||||||||||||
Non-gated Angigram of Chest, Abdomen and Pelvic arteries for vascular access selection | ECG gated CT of annulus and Aortic root for valve sizing selection | Left ventricles and other findings | Confirm severe Aortic Stenosis | ||||||||||||||||||||||||||||||||||||||||||||||||
Transfemoral Approach | Annular sizing | Aortic Root sizing | Additional Procedural Planning | ||||||||||||||||||||||||||||||||||||||||||||||||
Subclavian Approach | Major/Minor Dimension | Coronary Ostia height | Fluoroscopy Angulation | LVEF and LV dimension | High gradient AS | ||||||||||||||||||||||||||||||||||||||||||||||
Apical Approach | Area | Aortic Sinus to Commissure dimension | Bypass Grafts | Estimated Pulmonary pressure | Low gradient AS | ||||||||||||||||||||||||||||||||||||||||||||||
Other Approaches | Circumferences | Sinotubular Junction | RV to Chest wall position | Other valvular abnormalities | Reduced EF | ||||||||||||||||||||||||||||||||||||||||||||||
Carotid | Ascending Aorta dimension | Preserved EF | |||||||||||||||||||||||||||||||||||||||||||||||||
Direct Aortic | Aortic Calcification | ||||||||||||||||||||||||||||||||||||||||||||||||||
Transvenous | |||||||||||||||||||||||||||||||||||||||||||||||||||
TAVR Imaging Checklist | ||
---|---|---|
Region of Interest | Recommended Approach and Key
Measures |
Additional Comments |
Preprocedure | ||
Aortic valve morphology | TTE:
|
useful for subaortic membranes
nondiagnostic
contraindicated |
Aortic valve function | TTE:
|
Additional parameters
for LFLG AS-Reduced EF
diagnosis in question |
LV Geometry and other
cardiac findings |
TTE:
|
DSE, thallium
scar, identification of cardiomyopathies |
Annular sizing |
thorax with multiphasic acquisition
of the R-R window |
|
Aortic root measurements |
multiphasic acquisition.
|
sinus to sinus)
widest dimension, at level of PA)
|
Coronary disease and
thoracic anatomy |
|
|
Noncardiac imaging |
|
May be considered depending on clinical
history |